Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), sold 9,550 shares at $51.63 ($493K) on 2012-06-08, disclosed to the SEC on 2012-06-12.
Open-market sale of $493k SLXP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.63 | 2,550 | $132K | 26.7% |
| 2 | $51.63 | 7,000 | $361K | 73.3% |
| Total | $51.63 avg | 9,550 | $493K | 100% |
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |
| SLXP | BUY | 2011-08-11 | $21K | — | Filing → |